20399 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
HETEROCYCLIC COMPOUND AS TAAR1 LIGAND AGONIST
#2PHARMACOTHERAPY FOR OBSESSIVE-COMPULSIVE DISORDER TARGETING DOPAMINE D1 SIGNAL IN STRIATAL STRIOSOMES
#3POLYCYCLIC COMPOUND AND USE THEREOF
#4CYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#5PRMT5 INHIBITORS AND USES THEREOF
#6SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#7CYCLIC COMPOUNDS AND METHODS OF USING SAME
#8SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#9METHODS AND COMPOSITIONS FOR TREATING CANCERS HAVING F-BOX AND WD-REPEAT PROTEIN 7 (FBXW7) ALTERATIONS AND/OR CYCLIN L1 (CCNL1) GAIN OR AMPLIFICATION
#10COMPOSITIONS AND METHODS FOR TREATMENT OF A CORONAVIRUS DISEASE (COVID-19) INFECTION
#11APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES
#12THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM
#13METHODS INVOLVING DOWNREGULATING APOBEC3B
#14ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#15Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases
#16Piperidine derivative and preparation method and pharmaceutical use thereof
#17METHODS FOR DOWNREGULATING APOBEC3B
#18MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#19Use of physiological cooling active ingredients, and agents containing such active ingredients
#20METHODS AND COMPOUNDS FOR PHOTOTHERAPY WITH CHALCOGENORHODAMINE PHOTOSENSITIZERS
#21ROS1 inhibitor and its use
#22Antiviral axin stabilizer
#23Method for preparing spherical Clopidogrel Hydrogen Sulfate polymorph I
#24Compounds inhibiting eukaryotic elongation factor 2 kinase activity
#25Antiviral compounds and methods of use thereof
#26Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#27Use of physiological cooling active ingredients, and agents containing such active ingredients
#28Cancer therapy
#29Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#30Inhibitors of viral replication, their process of preparation and their therapeutical uses
#31Antiviral compounds and methods of use thereof
#32Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#33Use of physiological cooling active ingredients, and agents containing such active ingredients
#34Parenteral formulation of clopidogrel
#35Solid dispersions containing kinase inhibitors
#36COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME
#37METHODS FOR INCREASING WHITE BLOOD CELLS
#38INHIBITION OF PLATELET AGGREGATION
#39Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors
#40Hydroxylthienoquinolones and related compounds as anti-infective agents
#41PREVENTIVE AND THERAPEUTIC MEDICAMENT FOR GASTROESOPHAGEAL REFLUX DISEASE
#42Preventive and therapeutic medicament for gastroesophageal reflux disease
#43Azabicycloalkane compounds
#44PREVENTIVE AND THERAPEUTIC MEDICAMENT FOR GASTROESOPHAGEAL REFLUX DISEASE
#45Compositions Useful For Treating Irritable Bowel Syndrome
#46Drug-surfactant complexes for sustained release
#47METHODS FOR TREATING HEPATITIS C
#48Thienopyridine and furopyridine kinase inhibitors
#49Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#50Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#51Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
#52Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#53PHARMACEUTICAL COMPOSITIONS CONTAINING CLOPIDOGREL BISULFATE
#54MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#55Modulation of cell fates and activities by phthalazinediones
#56Preventive and Therapeutic medicament for gastroesophageal reflux disease
#57COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME
#58ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
#59Azabicycloalkane compounds
#60USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
#61TOPICAL CERAMIDE COMPOSITIONS AND METHODS OF USE
#62Use of SERP-1 as an antiplatelet agent
#63Selective resonant reconfiguration of chemical structures
#64Oral dosage forms including an antiplatelet agent and an acid inhibitor
#65Combination therapy for coronary artery disease
#66Thienopyridine and furopyridine kinase inhibitors
#67Modulation of cell fates and activities by phthalazinediones
#68Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#69Drug-surfactant complexes for sustained release
#70Selective resonance of bodily agents
#71Compositions and methods for treating gastrointestinal hypomotility and associated disorders
#72Nanoparticulate clopidogrel and aspirin combination formulations
#73Preventive and therapeutic medicament for gastroesophageal reflux disease
#74SYNERGISTIC MODULATION OF FLT3 KINASE USING THIENOPYRIMIDINE AND THIENOPYRIDINE KINASE MODULATORS
#75Lklf/klf2 gene expression promoter
#76Compounds for inhibiting KSP kinesin activity
#77Method for treating cardiovascular diseases
#78Inhibition of platelet aggregation
#79Use of N-desmethylclozapine to treat human neuropsychia tric disease
#80Use of N-desmethylclozapine to treat human neuropsychiatric disease
#81Pharmaceutically active compounds and methods of use
#82Use of SERP-1 as an antiplatelet agent
#83Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
#84Kinase inhibitors as therapeutic agents
#85Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#86Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#87Neuroprotective effect of solubilized UDCA in focal ischemic model
#88Methods for treating hepatitis C
#89Modulation of cell fates and activities by phthalazinediones
#90Preventive and therapeutic medicament for gastroesophageal reflux disease
#91Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
#92Use of N-desmethylclozapine to treat human neuropsychiatric disease
#93Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof
#94Medicinal composition for treating arteriosclerosis
#95Pharmaceutical compositions based on anticholinergics and additional active ingredients
#96Racemization and enantiomer separation of clopidogrel
#97Thienopyridine and furopyridine kinase inhibitors
#98Sulfide and disulfide compounds and compositions for cholesterol management and related uses